Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years of age

Vaccination offers the best way to prevent invasive meningococcal disease (IMD). As demonstrated in countries with national immunization programs (NIPs) against IMD, meningococcal conjugate vaccines have contributed to significant declines in incidence. Since some meningococcal vaccines are associat...

Descripción completa

Detalles Bibliográficos
Autores principales: Marshall, Gary S., Pelton, Stephen I., Robertson, Corwin A., Oster, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Meningococcal – Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746432/
https://www.ncbi.nlm.nih.gov/pubmed/35947774
http://dx.doi.org/10.1080/21645515.2022.2099142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746432/
https://www.ncbi.nlm.nih.gov/pubmed/35947774
http://dx.doi.org/10.1080/21645515.2022.2099142

Ejemplares similares